Layered double hydroxide nanoparticles as cellular delivery vectors of supercoiled plasmid DNA by Xu, Zhi Ping et al.
International Journal of Nanomedicine 2007:2(2) 163–174
© 2007 Dove Medical Press Limited. All rights reserved
163
REVIEW
Layered double hydroxide nanoparticles 
as cellular delivery vectors of supercoiled 
plasmid DNA
Zhi Ping Xu1 
Tara L Walker2 
Kerh-lin Liu1 
Helen M Cooper2 
GQ Max Lu1 
Perry F Bartlett2
1ARC Centre for Functional 
Nanomaterials, Australian Institute of 
Bioengineering and Nanotechnology; 
2Queensland Brain Institute, The 
University of Queensland, Brisbane, 
QLD 4072, Australia
Correspondence: GQ Max Lu
ARC Centre for Functional 
Nanomaterials, Australian Institute of 
Bioengineering and Nanotechnology, 
The University of Queensland, Brisbane, 
QLD 4072, Australia
Tel +61 7 3365 3885 
Fax +61 7 3365 6074
Email maxlu@uq.edu.au
Abstract: We prepared stable homogeneous suspensions with layered double hydroxide (LDH) 
nanoparticles for in vitro gene delivery tests. The viability of HEK 293T cells in the presence 
of LDH nanoparticles at different concentrations was investigated. This revealed 50% cell 
viability at 500 μg/mL of LDH nanoparticles that is much higher than 50–100 μg/mL used for 
the delivery tests. The supercoiled pEF-eGFP plasmid (ca. 6100 base pairs) was mixed with 
LDH nanoparticle suspensions for anion exchange at a weight ratio of DNA/LDH between 1:25 
and 1:100. In vitro experiments show that GFP expression in HEK 293T cells starts in the ﬁ  rst 
day, reaches the maximum levels by the second day and continues in the third day. The GFP 
expression generally increases with the increase in DNA loading in DNA-LDH nanohybrids. 
However, the delivery efﬁ  ciency with LDH nanoparticles as the agent is low. For example, 
the relative efﬁ  ciency is 7%–15% of that of the commercial agent FuGENE®6. Three to 6% 
of total cells expressed GFP in an amount detectable by the FACS cytometry 2 days after 
transfection at 1 μg/mL of plasmid DNA with 25 μg/mL of LDH nanomaterial. The lower 
delivery efﬁ  ciency could be attributed to the aggregation of LDH nanoparticles caused by the 
long-chain plasmid DNA.
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Introduction
Over the past few decades, scientists have been searching for suitable gene delivery 
systems to realize the dream of overcoming human genetic diseases. Many types of 
nonviral vectors (Pouton and Seymour 1998; Luo and Saltzman 2000; Dietz and Bahr 
2004; Leong 2005; Xu et al 2006a), including liposomes, cationic polymers (Pouton 
and Seymour 1998; Luo and Saltzman 2000; Leong 2005), recombinant proteins (Dietz 
and Bahr 2004) and inorganic nanoparticles (Xu et al 2006a), have been widely inves-
tigated. However, their clinical applications have been limited by the inefﬁ  ciency in 
a few consecutive processes: cellular uptake, release of the gene from the endosome, 
and nuclear targeting and transport (Khalil et al 2006; van der Aa et al 2006). It is 
expected that advances in nanoscale materials sciences, such as the control of particle 
size and shape, the variety of the particle surface properties, the proper fusion of DNA 
fragment with the nanoparticles and the suitable release of DNA from the particles will 
overcome these barriers, leading to higher-efﬁ  ciency DNA delivery (Xu et al 2006a). 
Currently, the design of safe and efﬁ  cient gene delivery systems remains one of the 
key challenges in gene therapy (Nielsen 2005). 
In recent years, increasing efforts worldwide have been devoted to develop-
ing various inorganic materials as novel nonviral delivery systems (Barbe et al 
2004; Xu et al 2006a). This is due to the recognition that inorganic nanoparticles 
generally possess versatile properties suitable for gene delivery, including wide International Journal of Nanomedicine 2007:2(2) 164
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availability, rich functionality, good biocompatibility, 
potential capability of target delivery and controlled 
release of carried genes. Amongst these, layered double 
hydroxide nanomaterial appears to be an outstanding 
candidate. 
LDHs are a group of anion-exchanging materials 
containing mixed metal hydroxides similar to brucite, 
Mg(OH)2. In a brucite layer, each Mg2+ ion is octahedrally 
surrounded by six OH– ions and the different octahedra 
share edges to form an inﬁ  nite 2D layer. In hydrotalcite 
[Mg6Al2(OH)16][CO3·4H2O], the replacement of Mg2+ 
by Al3+ gives the brucite-like layer positive charges that 
are balanced by carbonate anions located in the inter-
layer region. The positively charge brucite-like layers 
([Mg6Al2(OH)16]2+), interlayer anions as well as water 
molecules ([CO3·4H2O]2–) are held together via electrostatic 
interactions and hydrogen bonds to form a 3D structure 
(Cavani et al 1991; Braterman et al 2004). In general, LDHs 
can be chemically expressed by a formula like [M M 1x
2+
x
3+
−
(OH)2]x+ [(Am–)x/m · nH2O]x–, where M2+ can be most divalent 
cations such as Mg, Zn, Ni, Co, and Fe, M3+ most trivalent 
cations such as Al, Fe, and Cr, and Am– the exchangeable 
anions, such as CO Cl SO 3
2−− − ,, 4
2 , various organic anions 
and complex anions. 
LDHs can be readily synthesized in the laboratory 
with controllable lateral size between 40 and 300 nm 
(Xu et al 2006b). A number of experiments have been 
reported involving the intercalation (loading) of nucleo-
tides, oligonucleotides and genes into the LDH interlayer 
(Choy et al 1999, 2000; Kriven et al 2004; Desigaux et al 
2006), the cytotoxicity of LDH materials to the cells 
(Kriven et al 2004; Tyner et al 2004), the cellular uptake 
of LDH nanoparticles (Choy et al 2000, 2001; Tyner 
et al 2004), and the in vitro gene transfection tests in 
different cell lines (Choy et al 2000; Tyner et al 2004) 
as well as target delivery by conjugating the antibody 
protein (Tyner et al 2004). These investigations indicate 
that LDH nanomaterial could be used as an effective 
gene delivery system. In advancing this expectation, we 
prepared Mg2Al-Cl-LDH nanoparticles in 50–300 nm with a 
regularly hexagonal platelet shape, loaded a pEF-eGFP 
plasmid (ca. 6100 base-pairs) to LDH nanoparticles, and 
transfected a mammalian cell line (HEK 293T) in vitro. 
We have also re-examined the cytotoxicity of Mg2Al-
Cl-LDH nanoparticles in this paper. The observations 
show that LDH nanoparticles can be used as a potential 
nonviral delivery system, but need further optimization 
to enhance the delivery efficiency. 
Materials and methods
Preparation of LDH nanoparticle 
suspensions
Layered double hydroxides (LDHs) were prepared by 
co-precipitation and subsequent hydrothermal treatment. 
In brief, the pristine Mg2Al(OH)6Cl·1.5H2O was prepared 
by quickly adding 10 mL of mixed salt solution containing 
MgCl2 (3.0 mmol) and AlCl3 (1.0 mmol) (within 5 seconds) 
into 40 mL of NaOH solution (0.15 M, just enough for form-
ing Mg2Al-LDH) to coprecipitate under vigorous stirring, 
followed by 10-minute stirring with the reactor isolated 
from air (Boclair and Braterman 1999; Xu et al 2006b). The 
Mg2Al(OH)6Cl·1.5H2O slurry was obtained via centrifuge 
separation, followed by washing twice with deionized water. 
The washed slurry was then manually dispersed in 40 mL 
of deionized water and transferred into a stainless steel au-
toclave with a Teﬂ  on lining. The autoclave was then placed 
in a pre-heated oven and heated at 100 °C for 16 hours to 
give rise to a stable homogeneous LDH suspension after 
air-cooling. As-obtained LDH suspension generally contains 
hexagonal sheet-like nanoplates with an approximate com-
position of Mg2Al(OH)6(Cl)·1.5H2O at a concentration of 
ca. 0.4 wt%. LDH suspensions with ca. 0.8 wt% and ca. 0.2 
wt% were also prepared in the similar way. The pH of 8.5 
in such suspensions was normally adjusted to 7.5 by adding 
one volume of sterile salt solution (2 mM MgCl2 and 1 mM 
AlCl3) into three volumes of LDH suspensions.
DNA-LDH nanohybrids 
The supercoiled pEF-eGFP plasmid was prepared using the 
Qiagen maxiprep kit and diluted in deionized water at a ﬁ  nal 
concentration of 1 μg/μL. The DNA:LDH weight ratio in 
the DNA-LDH nanohybrid suspensions was ﬁ  xed at 1:25, 
1:50 or 1:100. For example, to make DNA-LDH suspesn-
ion with DNA:LDH weight ratio of 1:50, 100 μL of LDH 
suspension (0.80 wt%), 16 μL of plasmid DNA (1 μg/μL), 
50 μL of sterile water and 34 μL of sterile Mg-Al buffer 
solution were mixed and shaken at 37 °C for 4 hours in a 
sealed sterile tube.
Cell culture and cytotoxicity assay
Human Embryonic Kidney (HEK 293T) cells were cultured 
in RPMI 1640 growth medium (Invitrogen) supplemented 
with 10% Fetal Calf Serum (FCS), 100000 U/L penicillin 
and 50 mg/L streptomycin. In a typical cytotoxicity assay, 
HEK 293T cells were seeded in 6-well plates at a density of 
100,000 cells in 3.0 mL growth medium per well and allowed International Journal of Nanomedicine 2007:2(2) 165
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to incubate overnight at 37 °C in the atmosphere of 5% CO2. 
After 24-hour incubation, the medium was removed and 
replaced with 3.0 mL of the fresh growth medium containing 
various amounts of LDH nanomaterial, eg, from 25 to 2000 
μg/mL. A control experiment was performed without LDH 
under the same conditions. After 48 hours of incubation, cells 
were collected and stained with Trypan Blue, and the live 
cells were counted using a hemocytometer under Olympus 
CKX31 microscope. Cell viability was then calculated as 
the percentage of the live cell number Ntest over the number 
Ncontrol in the control experiment, ie, Ntest/Ncontrol × 100. The 
tests were performed in triplicate.
Delivery test and FACS analysis
HEK 293T cells were seeded in 6-well plates at a density of 
100,000 cells per well and allowed to incubate at 37 °C in 
the atmosphere of 5% CO2 for 24 hours. The growth medium 
was then removed and replaced with 3.0 mL of fresh growth 
medium that contained a certain amount of DNA-LDH nano-
hybrids. After 1-, 2-, or 3-day incubation, cells were imaged 
using a ﬂ  uorescence microscope (Olympus IX 81). The 
cells in each well were then harvested by trypsinization and 
resuspended to a ﬁ  nal volume of 1.0 mL phosphate-buffered 
saline. Cells in the suspension were sorted by the ﬂ  ow 
cytometry (λ = 530 nm) on a BDTM LSRII FACS (Fluores-
cence activated cell sorting) Analyzer, and a total of 30,000 
cells were counted for each sample for statistical analysis. 
The commercial transfection agent FuGENE®6 (Roche) was 
used in parallel with the above delivery tests.
Characterization
Photon correlation spectroscopy (PCS, Nanosizer Nano ZS, 
MALVERN Instruments) was used to analyze the particle 
size distribution from 0.6 to 6000 nm and Zeta potential 
from –200 to 200 mV of the LDH suspensions, in which 
the peak positions as well as the polydispersion index (PDI) 
were automatically calculated. The transmission electron 
microscopic images were obtained on a JEOL JSM-2010 
transmission electron microscope (TEM) at an acceleration 
voltage of 200 kV. STEM (scanning transmission electron 
microscopy) images and EDS (energy dispersive X-ray 
spectrometry) spectra were recorded in a Philips Tecnai 20 
FEG analytical electron microscope. For TEM and STEM 
imaging, the freshly collected LDH nanoparticles were dis-
persed in alcohol with ultrasonication for 20 min and then 
a droplet was dropped on a copper grid coated with carbon 
ﬁ  lm. X-ray diffraction patterns were measured for LDH ma-
terials collected via high-speed centrifugation at a scanning 
rate of 1.2° per minute from 2θ = 5° to 2θ = 75° with Co Kα 
radiation (λ = 0.17902 nm) on a Rigaku Miniﬂ  ex X-ray dif-
fractometer with a variable slit width. Infrared spectra were 
collected on a Perkin-Elmer 2000 FTIR after 40 scans within 
4000–400 cm–1 at a resolution of 4 cm–1 by measuring the IR 
absorbance of KBr disc that contains 1–2 wt% of sample. 
In addition, the metal contents of suspension samples were 
determined by inductively coupled plasma and atomic emis-
sion spectroscopy (ICP-AES) on a Varian Vista Pro. 
Results and discussion
Pristine LDH nanoparticle suspensions
The LDH suspensions visually look very transparent and 
homogeneous. The pristine LDH materials collected from the 
suspensions via high-speed centrifugation have the typical 
layered features, as reﬂ  ected by the X-ray diffraction pattern 
in Figure 1. Very sharp and strong diffractions from planes 
(003) and (006) demonstrate an ordered layer stacking. The 
interlayer spacing is 0.7633 nm and lattice parameter a is 
0.3046 nm for the pristine LDH (Mg2Al-Cl-LDH), quite 
similar to those reported elsewhere (Cavani et al 1991; 
Boclair and Braterman 1999). 
Similarly, the FTIR spectrum in Figure 2 is typical of 
Mg2Al-LDH materials, as featured by a broad band at 3450 
cm–1 (νOH), a weak peak at 1620 cm–1 (δH2O), bands at 678 and 
447 cm–1 (due to M-O vibrations and M-O-H bending). The 
weak peak at 1365 cm–1 is due to the stretching vibration of 
CO3
2– that is converted from CO2 captured from air during 
washing) (Hernandez-Morento et al 1985; Nakamoto 1997; 
Xu and Zeng 2001). In particular, the sharp peak at 447 
cm–1 and the shoulder over 3450 cm–1 are the evidences of 
Mg2Al-LDH (Hernandez-Morento et al 1985; Xu and Zeng 
2001). Elemental analysis gives the atomic ratio [Mg]/[Al] 
close to 1.9, slightly less than the designed value (2.0), 
attributed to more Mg2+ leaching than Al3+ from the hydroxide 
layers during the hydrothermal treatment (Xu et al 2006b). 
The leaching of Mg2+ may lead to formation of traces of 
gibbsite and brucite, as marked with # and * in Figure 1, 
respectively.
The stable homogeneous Mg2Al-Cl-LDH suspension 
typically has a narrow particle size distribution, centred 
at an average hydrodynamic diameter of ca. 122 nm and a 
narrow zeta potential distribution at ca. 39.4 mV (Figure 3). 
The hydrodynamic particle diameter is exclusively falling 
in the range of 40–400 nm and 95% in 50–300 nm, with 
a polydispersion index (PDI) of 0.12. The TEM image in 
Figure 4 shows that the pristine LDH nanoparticles are well 
shaped hexagonally as usual (Cai et al 1994), with the lateral International Journal of Nanomedicine 2007:2(2) 166
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Figure 1 XRD pattern of pristine Mg2Al-Cl-LDH nanomaterials. 
Note: *brucite; #gibbsite.
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Figure 2 FTIR spectrum of pristine Mg2Al-Cl-LDH nanomaterials. Shoulder with # is characteristic of Mg2Al-Cl-LDH.International Journal of Nanomedicine 2007:2(2) 167
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Figure 3 (A) Particle size distribution and (B) Zeta potential distribution of pristine Mg2Al-Cl-LDH nanoparticle suspension. 
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Figure 4 TEM image of typical Mg2Al-Cl-LDH.
dimension in 50–150 nm from this image. These hexagonal 
nanoplates are well separated from one another, with very 
limited casual inter-connection. The lateral dimension from 
TEM images is statistically equivalent to the hydrodynamic 
diameter from PCS although the thickness is much smaller 
than the lateral dimension. The thickness of LDH nanopar-
ticles is estimated to be ~15 nm from the full-width-at-half-
maximum of XRD diffraction peaks (003) and (006) (Cullity 
1978) or 8–16 nm from a few TEM images, giving an aspect 
ratio of 5–10.  
LDH-DNA nanohybrids
When plasmid DNA is added into the MgAl-Cl-LDH suspen-
sion, DNA chains should exchange with the chloride anions 
and intercalate into the LDH interlayer spacing, at least par-
tially. As reported by Desigaux and colleagues (2006), DNA 
fragments with 100–500 and 6000–8000 base pairs can be 
intercalated at temperatures from 25 to 60 °C. In the current 
research, however, the DNA amount is much smaller than 
that required for the full exchange reaction. For example, in a 
typical delivery test, 80 μg of plasmid DNA is reacted with 1.0 
mL of the LDH suspension which contains 4.0 mg of LDH, 
ie, the weight ratio of DNA:LDH is 1:50. This means that the 
added plasmid DNA can only exchange 1.5% Cl– in LDH 
theoretically1. Such a small portion of DNA-LDH hybrids 
could not induce noticeable diffraction in the XRD pattern. 
However, the addition of DNA to the LDH suspension has 
indeed caused the some LDH nanoparticles to agglomerate 
into aggregates. As shown in Figure 5A, a large DNA-LDH 
aggregate recorded with STEM contains a number of LDH 
nanoparticles, some of which are hexagonally shaped as usual. 
The aggregates are even visually observable when more DNA 
is added into the LDH suspension, for example, at DNA:LDH 
weight ratio up to 1:10. This aggregation could be due to the 
interactions of the supercoiled plasmid DNA with a few LDH 
nanoparticles. It is reasonable to assume that the supercoiled 
plasmid size is at least 200–300 nm (Ma and Bllomﬁ  eld 1994; 
Marko and Siggia 1995). Therefore, one DNA supercoil 
1The ratio of DNA negative charges over Al (2[b.p.]/[Al]) is roughly 1.5:100 
when the weight ratio of DNA/LDH is 1:50 as an average base pair molecular 
weight is 660 with two negative charges and LDH has molecular weight of 
250 with one positive charge.International Journal of Nanomedicine 2007:2(2) 169
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Figure 5 (A) STEM image and (B) EDX spectrum of DNA-LDH nanohybrids.
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Figure 6 HEK 293 cell viability versus Mg2Al-Cl-LDH concentration.
cannot be intercalated into only one LDH nanoparticle (about 
100 nm), ie, some parts of DNA fragment must be outside of 
this LDH nanoparticle. These parts may be simply exposed 
to aqueous solution, but more likely, intercalated into other 
LDH nanoparticles due to its high afﬁ  nity for LDH via elec-
trostatic interactions (Desigaux et al 2006). Thus, a few LDH 
nanoparticles interconnected by the DNA supercoil can lead 
to the formation of a big aggregate. 
In addition, the element analysis for the marked dot (Fig-
ure 5A), based on the STEM EDS spectrum (Figure 5B), ﬁ  rst 
indicates the existence of Mg (1.2 keV) and Al (1.5 keV) in 
considerable amount. The phosphorus element, only attributed 
to the DNA chain, is detected in a marginal amount at around 
2 keV in the EDS spectrum, possibly showing the existence of 
the plasmid DNA that is embedded within this aggregate. 
Cytotoxicity of LDH nanomaterials
The viability of HEK 293T cells in the presence of Mg2Al-
Cl-LDH nanomaterial at various concentrations is shown in 
Figure 6. Mg2Al-Cl-LDH has a lower degree of cytotoxicity 
although it gives an obvious decrease in cell viability after 2 
days at a concentration over 200 μg/mL. 50% cell viability 
occurs at a concentration of around 500 μg/mL. As expected, 
increase in the LDH concentration leads to higher cell death. 
For example, at 1000 μg/mL of LDH only ca. 30% HEK 
293T cells are viable and almost 100% cell death is observed 
at 2000 μg/mL of LDH. This observation conﬂ  icts with the 
report by Choy et al. who claim that Mg2Al-LDH at 1000 
μg/mL does not affect the viability of HL-60 cells (Kriven 
et al 2004). This difference may indicate that LDH material 
shows variable toxicity in different cell lines. In addition, 
the slightly higher Mg2+ concentration in the buffer (2mM 
MgCl2 and 1mM AlCl3) may have additional toxic effects 
on cells in our tests.
We have noted that Mg2Al-LDH at concentration of 
200–500 μg/mL causes some cell death. However, this con-
centration is much higher than the concentration (50–100 
μg/mL) used in our gene delivery tests, indicating LDH is 
a safe material for the gene delivery. In comparison, LDH 
has a much lower cytotoxicity than polymeric materials. For 
example, 10 μg/mL of PEI can cause 50% cell death (Choi 
et al 2004). Therefore, if LDH has a transfection efﬁ  ciency 
higher than or comparable with that of polymeric materials, 
LDH should be a more appropriate and promising system 
for the gene delivery. 
Although the exact mechanism of the cytotoxicity is not 
well understood, it is believed that this is due in part to mem-
brane disruption. As reported by Sayes et al for the cytotoxicity 
of C60 (Sayes et al 2004, 2005), C60 leads to lipid peroxidation 
and therefore disrupts the cell membrane (Chen et al 2005). 
As for LDH nanoparticles, the positive charges on the particle 
surface may bind the nanoparticles to the external membrane, 
especially at a higher concentration. When the whole cell 
membrane is covered by LDH nanoparticles and most particles 
are not internalized, the normal functions of cells may be 
interrupted, thus causing some irritation or damage to the cell 
membrane and leading to apoptosis (Rhaese et al 2003). In this 
regard, not only the composition of LDH nanomaterials, but 
also the charge density and particle size of LDH nanoparticles 
are primary factors determining the cytotoxicity. Moreover, International Journal of Nanomedicine 2007:2(2) 171
Nanoparticles as cellular delivery vectors of supercoiled plasmid DNA
Figure 7 Fluorescence microscopic images of cells with GFP expressed two days after transfection. (A) and (C): using LDH nanoparticles; (D): using the commercial agent 
FuGENE®6 as transfection agent ([DNA] = 1.0 μg/mL and [FuGENE®6] = 5.0 μg/mL?). (B): brightﬁ  eld image of image (A). 
the cytotoxicity of  LDH nanomaterials on different cell types 
should also be investigated. 
Transfection of HEK 293T cells
DNA-LDH nanohybrid particles were assessed for in vitro 
transfection efﬁ  ciency in HEK 293T cells, in comparison 
with the delivery of naked plasmid DNA and DNA-
FuGENE®6 particles where FuGENE®6 is a commercial 
polymeric transfection reagent. As expected, there is no 
expression of GFP with naked DNA for 1–3 days at 
concentrations between 0.25 and 2.0 μg/mL. With LDH 
nanoparticles as the gene delivery agent, some expression 
of GFP was evident as ﬂ  uorescent cells were observed 
following transfection after 1 day. More ﬂ  uorescent cells 
were seen after 2 or 3 days with brighter ﬂ  uorescence. As 
shown in Figure 7A, three bright ﬂ  uorescent HEK 293T 
cells are observed in this ﬁ  eld of view after transfection 
with LDH at DNA:LDH weight ratio of 1:25 (1.0 μg/mL 
DNA) after 2 days. The corresponding bright-ﬁ  eld image 
(Figure 7B) indicates most cells are viable. In another 
batch of tests (DNA:LDH weight ratio was 1:50 and DNA 
concentration was 1.0 μg/mL), more weakly ﬂ  uorescing 
cells were observed 2 days after transfection (Figure 7C). 
We have also tested the transfection under slightly different 
conditions. For example, DNA concentration was varied 
at 0.25, 0.5, 1.0 and 2.0 μg/mL with DNA:LDH weight 
ratio being 1:25, 1:50 or 1:100. Although visual observa-
tion and FACS data (in the following section) have not 
revealed an optimum condition, it seems that [DNA] = 1.0 
μg/mL with DNA:LDH weight ratio of 1:25 leads to better 
transfection. In these experiments, all individual tests show 
a similar trend in that cells with more GFP expression and 
therefore increasing ﬂ  uorescence intensity are related to 
the increase in DNA concentration and incubation time up 
to 3 days (details are given in the next section). Generally, 
3 days after transfection, ﬂ  uorescent cells do not increase 
in number and there is higher cell death due to the limited 
supply of nutrition.
As shown in Figure 7D, many more HEK 293T cells 
are transfected with the commercial agent FuGENE®6 
under very similar conditions. Figures 7C and 7D indi-
cate that the transfection efficiency using LDH nanopar-
ticles as the agent is approximately 10% of that using 
FuGENE®6. International Journal of Nanomedicine 2007:2(2) 172
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Figure 8 FACS proﬁ  le of HEK 293T cells with GFP proteins transfected under various conditions. (A) Controlled experiment; (B) 1.0 μg/mL of plasmid DNA; (C) 100 
μg/mL of LDHs; (D) 0.25 μg/mL of DNA and 25 μg/mL of LDH; (E) 0.50 μg/mL of DNA and 25 μg/mL of LDH; (F) 1.0 μg/mL of DNA and 25 μg/mL of LDH.
FACS analysis
Fluorescence activated ﬂ  ow cytometry was used to measure 
how many cells express the green ﬂ  uorescent protein and how 
much of this ﬂ  uorescent protein is expressed. The typical 
ﬂ  uorescence FACS proﬁ  les are shown in Figure 8, separated 
by the line with ﬂ  uorescence intensity of 2000, below which 
the ﬂ  uorescence is attributed to the background and above 
which the ﬂ  uorescence is due to the transfected cells as well 
as dead cells. Obviously, there are no ﬂ  uorescent cells in the 
control experiment (Figure 8A) 2 days after transfection. As 
expected, the plasmid DNA does not lead to any transfection 
by itself (Figure 8B). Unexpectedly, some cells (0.6%, Figure 
8C) seem to ﬂ  uorescence at 100 μg/mL of LDH, possibly due 
to the autoﬂ  uorescence of dead cells. As shown in Figure 6, 
the cell viability is slightly reduced at 100 μg/mL of LDH 
nanoparticles, and thus some dead cells are likely to be pres-
ent. Further shown in Table 1, there were 0.4%–0.5% cells 
showing the ﬂ  uorescence after 1- and 2-day incubation, and 
thus it is expected that 25 μg/mL of LDH (normally used 
for DNA delivery in this research) would cause much less 
cell death, possibly ca. 0.1% of cell population, so the effect 
of LDH materials on the GFP ﬂ  uorescence of cells can be 
ignored for data analysis in these tests. However, 3-day 
incubation led to much more cell death, largely due to the 
continuous inﬂ  uence of LDH on cell viability with the limited 
supply of nutrition.
Using LDH nanoparticles causes a signiﬁ  cant increase 
in the number of ﬂ  uorescent cells. As shown in Figures 
8D–8F, many more dots (cells) are above the line 2 days 
after transfection with LDH-DNA nanohybrids. As the DNA 
dose increases from 0.25 to 1.0 μg/mL while LDH concen-
tration is kept at 25 μg/mL, the percentage of ﬂ  uorescent 
cells increases from 1.0% to 4.1%. Table 1 shows that the 
average percentage of GFP-expressed cells increases with 
the increase in the plasmid DNA concentration in LDH-DNA 
nanohybrids. This implies that the DNA-LDH hybrids enter 
into cells in a DNA dose dependent manner (Choy et al 
2000). In addition, Table 1 also shows effect of the incuba-
tion time. For example, ca. 1.13% cells were transfected 
after 1 day while this percentage increased to 3.95% after 
day 2 of transfection and then decreased to 3.27% 3 days 
after transfection at the DNA concentration of 1.0 μg/mL. 
As the nutrition became limited and the cell conﬂ  uence was 
high in the third day, the percentage of ﬂ  uorescent cells 
decreased. However, the median ﬂ  uorescence intensity 
reaches maximum after day 3. 
In summary, the transfection efficiency using LDH 
nanoparticles as the agent is still relatively low. Our FACS data 
suggest that the percentage of transfected cells is ca. 3%–6% 
2 days after transfection. In comparison with the commercial 
agent FuGENE®6, the number of ﬂ  uorescent cells are about 
10% under the similar conditions, as seen in the images of International Journal of Nanomedicine 2007:2(2) 173
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Figures 7C and 7D. This relative transfection efﬁ  ciency 
also varies from 7% to 15% with the DNA concentration at 
0.25–2.0 μg/mL under similar experimental conditions. 
Factors affecting transfection efﬁ  ciency
The low delivery efﬁ  ciency may indicate that the barriers 
for delivery into the cell nucleus, such as the cellular uptake 
(endocytosis), endosomal escape, dissociation of the plasmid 
DNA and nuclear trafﬁ  cking, are not effectively overcome. 
The main factor causing such low transfection efﬁ  ciency, in 
our belief, is DNA-LDH hybrid particle size.
It is suggested that particles less than about 150 nm in 
diameter are preferred for endocytosis (Prabha et al 2002; 
Leong 2005). However, as discussed previously, aggregation 
of LDH nanoparticles in the presence of DNA can lead to the 
DNA-LDH hybrid particle size of 500–1000 nm (Figure 5A), 
much bigger than 150 nm. This directly reduces the cellular 
uptake by endocytosis. In addition, the bigger DNA-LDH 
aggregates are not well dispersed in the growth medium due 
to the relatively quick sedimentation, so that some cells in the 
wells are not readily exposed to the LDH-DNA nanohybrids 
and have less chance to be transfected. In this regard, LDH 
nanoparticles seem not suitable for delivering long chain 
DNA fragments (linear or supercoiled), such as those with 
more than 1000 base pairs.
In addition, the DNA-LDH nanohybrids have to escape 
from the endosome after passing through the cell membrane. 
The DNA-LDH nanohybrids have to then release the plasmid 
DNA fragment. During these two processes, the parts of 
the DNA fragment outside of LDH nanoparticles that are 
exposed to the environment could be attacked by enzymes 
and degraded (Choy et al 2000). Furthermore, the released 
naked DNA fragment could also be degraded during its 
translocation to the nucleus. The liability of gene degradation 
in these several processes ﬁ  nally reduces the chance for the 
plasmid DNA to reach the nucleus and be transcribed into 
GFP mRNA. 
Conclusions
Pristine Mg2Al-Cl-LDH nanoparticles were prepared with the 
lateral size of 50–300 nm. The positive zeta potential of 39 mV 
makes it very suitable for cellular uptake. This high positive 
charge on the LDH surface, however, makes it more likely to 
adhere to the cell membrane, interfere with cellular functions 
and cause cell death at high concentrations of LDH materials. 
The tests for supercoiled pEF-eGFP plasmid delivery indicate 
that this nanomaterial can be used as a nonviral system for gene 
delivery, however the delivery efﬁ  ciency is low under current 
conditions. Brieﬂ  y, ca. 3%–6% of total cells successfully ex-
pressed the GFP protein, corresponding to 7%–15% efﬁ  ciency 
of that using the commercial agent FuGENE®6 under similar 
conditions. The major factor leading to the low efﬁ  ciency 
could be attributed to the aggregation of LDH nanoparticles 
with the long-chain DNA.
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Figure 9 FACS proﬁ  le of HEK 293T cells with GFP proteins transfected after (X) 1 day, (Y) 2 days, and (Z) 3 days with 1.0 μg/mL of DNA and 25 μg/mL of LDH, respectively.
Table 1 The percentage of GFP-expressing cells (above the gate at ﬂ  uorescence intensity of 2000 in Figures 8 and 9).
Day DNA  onlya LDH  onlyb 0.25  μg/mL DNA in  0.50 μg/mL DNA in  1.0 μg/mL DNA in 
    LDH-DNAc LDH-DNAc LDH-DNAc
1 0.10  ±  0.05d  0.41 ± 0.10  0.40 ± 0.30  0.77 ± 0.39  1.13 ± 0.58
2  0.04 ± 0.02  0.49 ± 0.19  0.84 ± 0.42  3.23 ± 1.66  3.95 ± 1.48
3  0.04 ± 0.01  1.35 ± 0.50  0.97 ± 0.21  2.18 ± 1.41  3.27 ± 1.45
Note: aThe plasmid DNA concentration was 1.0 μg/mL in the tests; bThe LDH concentration was 100 μg/mL in the tests; cThe plasmid DNA concentration was varied at 
0.25, 0.50 and 1.0 μg/mL while the LDH concentration was kept at 25 μg/mL in the tests; dThe average percentage and standard deviation were calculated from the data in 
3 or 4 experiments.  International Journal of Nanomedicine 2007:2(2) 174
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